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Abstract
Background: Cancer screening programs hold much potential for reducing the cervical cancer disease burden in
developing countries. The aim of this study was to determine the feasibility of mobile health (mHealth) phone
technology to improve management and follow-up of clients with cervical cancer precursor lesions.
Methods: A sequential mixed methods design was employed for this study. Quantitative data was collected using
a cross-sectional survey of 364 women eligible for a Pap smear at public sector health services in Cape Town, South
Africa. Information was collected on socio-demographic status; cell phone ownership and patterns of use; knowledge
of cervical cancer prevention; and interest in Pap smear results and appointment reminders via SMS-text
messages. Descriptive statistics, crude bivariate comparisons and logistic regression models were employed to
analyze survey results. Qualitative data was collected through 10 in-depth interviews with primary health care
providers and managers involved in cervical cancer screening. Four focus group discussions with 27 women
attending a tertiary level colposcopy clinic were also conducted. Themes related to loss of mobile phones,
privacy and confidentiality, interest in receiving SMS-text messages, text language and clinic-based management
of a SMS system are discussed. Thematic analyses of qualitative data complemented quantitative findings.
Results: Phone ownership amongst surveyed women was 98% with phones mostly used for calls and short
message service (SMS) functions. Over half (58%) of women reported loss/theft of mobile phones. Overall,
there was interest in SMS interventions for receiving Pap smear results and appointment reminders. Reasons
for interest, articulated by both providers and clients, included convenience, cost and time-saving benefits
and benefits of not taking time off work. However, concerns were expressed around confidentiality of SMS
messages, loss/theft of mobile phones, receiving negative results via SMS and accessibility/clarity of language
used to convey messages. Responsibility for the management of a clinic-based SMS system was also raised.
Conclusions: Results indicated interest and potential for mHealth interventions in improving follow-up and
management of clients with abnormal Pap smears. Health system and privacy issues will need to be addressed for
mHealth to achieve this potential. Next steps include piloting of specific SMS messages to test feasibility and
acceptability in this setting.
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Background
Cervical cancer, the fourth commonest cause of cancer
deaths in women worldwide, remains a global public
health challenge [1]. In South Africa (SA), it is the sec-
ond most common cancer and the leading cause of
cancer mortality in women [2, 3]. Moreover, South Af-
ricans continue to face one of the worst human im-
munodeficiency virus (HIV) epidemics in the world
with approximately one fifth of South African woman
between 15 and 49 years currently living with the dis-
ease [4]. These women are at increased risk for human
papillomavirus (HPV) infection, the underlying cause
of cervical cancer; cervical precancerous lesions and;
cervical cancer [5, 6]. Without adequate screening and
treatment of cervical precancerous lesions, the bene-
fits of an expanded antiretroviral program in this con-
text will likely by offset by an increased burden of
cervical cancer.
A Papanicolaou (Pap) smear has long been regarded
as an effective cytology-based screening tool to detect
precancerous cervical abnormalities [7]. Further inves-
tigation of these abnormalities typically includes as-
sessment with a magnifying instrument (a colposcope)
that enables good visualization of the cervix. When
clients with abnormal Pap smears receive the neces-
sary screening, investigation and treatment, cervical
cancer can be prevented. In developed regions, orga-
nized cervical screening programs supported by well-
functioning recall systems have resulted in reduced
cervical cancer incidence and mortality [7, 8]. However,
in developing countries, cervical cancer remains a persist-
ent concern due to ineffective or absent screening pro-
grams, lack of awareness, health system challenges and
resource constraints [7, 9–11].
In SA, women over 30 years of age attending public
health facilities are eligible for three free Pap smears in
their lifetime [12]. Women who are HIV positive are
eligible for a Pap smear at diagnosis and every 3 years
if the screening test is negative. Women with abnormal
Pap smear results are referred for a colposcopy assess-
ment. Pap smear screening services are available at
most primary healthcare facilities, while colposcopies
are typically conducted at tertiary or secondary level
hospitals. Typically, clients are informed of their col-
poscopy appointments via postal recall system sent
directly from the laboratory or through their primary
health care clinic of origin.
A key challenge to successful implementation of cer-
vical screening programs in SA has been the loss to
follow-up of women with abnormal Pap smears at col-
poscopy appointments. A study on the challenges faced
by these women across three provinces in SA indicated
that, although appointments were made for all women
with high-grade squamous intraepithelial lesions, only
50% of the women attended [13]. Poor attendance oc-
curred despite improvements in interfacility linkages
and established paper-based feedback systems.
Various strategies and interventions in several
countries have been shown to improve colposcopy at-
tendance and screening program effectiveness, includ-
ing the use of reminder telephone calls and provision
of travel incentives [14]. In SA, repeated home visits
by community health workers have also shown some
efficacy [15]. However, these interventions are costly,
time-consuming and place additional burdens on
clinic staff. More recently, investigators have raised
the potential of mobile phone-based interventions,
including the use of short message service (SMS), as
a cost-effective alternative to delivering Pap smear re-
sults, improving waiting times and providing infor-
mation [16].
Mobile phones are one of the fastest growing tech-
nologies globally with over five billion unique mobile
subscriptions to date [17]. In SA, mobile phones have
reportedly penetrated 98% of households, reaching
more people than public water and sanitation services
[18]. Its near ubiquitous use makes it a compelling
tool for improving health service delivery and bridging
systematic gaps in access to care [19–21]. Mobile
health (mHealth), a broad term used to describe the
use of mobile communication technologies for the de-
livery and support of health care, is gaining increasing
attention [22, 23]. Several studies have described the
feasibility and benefits of mHealth technology in SA
to conduct research, health promotion, adherence
support and management of community-based social
and health services [24–30]. The use of mobile
phones, specifically SMS text messaging, is also be-
coming common for preventative health care [31].
However, there remains a shortage of evidence to sup-
port its use in cancer prevention, especially in devel-
oping contexts [32]. Against a backdrop of growing
access to, and increasing enthusiasm for, the use of
mHealth, this study explored the feasibility of using
mobile phones to improve the management and
follow-up of clients with cervical cancer precursor le-
sions in Cape Town, SA.
Methods
A sequential mixed methods design was employed for
this study. Quantitative data was collected first using a
cross-sectional survey of women eligible for a Pap smear
at public sector health services in Cape Town. Qualita-
tive data complemented the interpretation of quantita-
tive data and was collected through in-depth interviews
(IDIs) with primary health care providers and managers
and focus group discussions (FGDs) with first time col-
poscopy clinic attendees.
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Quantitative data
The cross-sectional survey was conducted between Feb-
ruary and June 2014 among women eligible for a pap
smear. The study sample was stratified by age. Women
between 18 and 30 years (n = 187) were recruited from 2
HIV care clinics and women ≥30 years (n = 177) recruited
from 2 primary health care clinics. Surveys were admin-
istered verbally by a trained researcher in the home lan-
guage of participants (English, Afrikaans or isiXhosa).
Information was collected on socio-demographic status;
cell phone ownership and patterns of use; knowledge of
cervical cancer prevention; and interest in Pap smear
results and appointment reminders via SMS-text mes-
sages using a structured questionnaire. Data was ana-
lyzed using STATA. Descriptive statistics were used to
characterize the variables and crude bivariate compari-
sons used to identify associations between patterns of
cell phone use, socio-demographics and other variables.
Bivariate comparisons were made using parametric
tests for categorical data (either chi-squared or Fisher
exact where n < 5 in a particular cell) or non-parametric
tests such as the Kruskal-Wallis test for data that were
not normally distributed. Logistic regression models
were employed to determine factors associated with
interest in receiving Pap smear results and interest in
receiving appointment reminders via SMS. Variables
entered into the models included those with p < 0.05
on bivariate analysis and those of a priori interest.
Where multicollinearity was present, we included vari-
ables in the model that minimized the negative log like-
lihood. HIV status and age showed collinearity as
anticipated given our recruitment process. We excluded
age, but included HIV status in the final model. The
model for interest in receiving Pap smear results via
SMS included education level (less than matric vs. ma-
tric or higher), reported HIV status, likelihood of SMS
being seen by others and past Pap smear. For interest
in receiving appointment reminders via SMS, the model
included education level (less than matric vs. matric or
higher), reported HIV status, likelihood of SMS being
seen by others, past Pap smear type and whether the
participant spoke Afrikaans.
Qualitative data
IDIs (n = 10) were conducted with primary health care
providers and managers between June and August 2014.
A researcher trained in qualitative interview techniques
used a semi-structured interview guide to elicit views
on the use and feasibility of mobile technology to im-
prove management of the cervical cancer screening
program. Additionally, four focus group discussions
(FGDs) were conducted with first-time colposcopy
clinic attendees (18 years and older) at a tertiary hos-
pital in Cape Town in November 2014. Discussions
lasted between 90 and 120 min and were conducted
predominantly in English, with Afrikaans and isiXhosa
translation provided where necessary. The following is-
sues were explored by a trained interviewer: challenges
to colposcopy clinic attendance; potential use of mobile
technology to improve adherence; and content of SMS-
text messages. The interviewer kept detailed reflective
notes during the IDIs and FGDs, which were used in
interpreting the results. Both IDI and FG discussions
were digitally-recorded, translated (where necessary)
and transcribed. Transcripts were reviewed by JM and
MM. Data were entered into QSR NVivo 10 (a qualita-
tive computer software package). A thematic analysis
was performed with initial coding categories for analyz-
ing data drawn from the interview guides. MM coded
the data and JM reviewed the coded data. Text seg-
ments were coded and categorized into basic themes.
Written informed consent was obtained from all par-
ticipants. Ethical approval to conduct the study was ob-
tained from the Human Research Ethics Committee,
University of Cape Town.
Results
The following section presents the profile character-
istics of each sample group followed by a narrative
discussion of integrated quantitative and qualitative
findings.
Participant profiles
Cross-sectional survey among women eligible for a pap
smear
A total of 412 women were approached to participate
in the survey. One declined and 40 did not meet the
age eligibility criterion. Of the remaining 371 partici-
pants, 364 (98%) owned a mobile phone. Results pre-
sented are based on the 364 participants (187 < 30
years and 177 ≥ 30 years) who reported current mobile
phone ownership. The main home language spoken
was isiXhosa, however the majority of participants
(87%) also spoke English (Table 1). Most participants
had a secondary or higher level of education. Among
women older than 30 years, 97% (171) were aware of
their HIV status. Of these 97% were prepared to dis-
close their status to the interviewer and 55% were HIV
positive.
In-depth interviews with health care providers
Interviews were conducted until data saturation was
reached. In total we interviewed three primary health
care clinic managers and seven nurse practitioners in-
volved in administering Pap smears. The majority of
providers were female (n = 8) and six were younger
than 40 years. On average, providers were involved in
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the Pap smear screening program for 3 years (range of
1–10 years).
Focus group discussions with colposcopy clients
Twenty-seven first time colposcopy clients participated
in four focus group discussions (6 or 7 participants per
group). The median age of participants was 34 years
(IQR 27–40 years). Eighteen out of 27 (67%) had a sec-
ondary school or higher level of education and 15/27
(56%) were unemployed. Twenty-four participants (89%)
owned a mobile phone.
During the qualitative IDIs and FGDs themes re-
lated to mobile phones loss, privacy and confidenti-
ality, interest in receiving SMS-text messages, text
language and clinic-based management of a SMS sys-
tem emerged and are presented in this paper. Themes
relating to women’s experiences with cervical cancer
screening also emerged during the FGDs and have been
discussed elsewhere [9].
Mobile phone ownership and patterns of phone use
among women eligible for a pap smear
Information on ownership and patterns of use were ob-
tained as part of the cross-sectional survey and are pre-
sented in Table 2. Younger women were significantly
more likely to own a smart or feature phone compared
to older women (68% vs. 55%, p = 0.001). The majority
of participants (97.9%) owned their current subscriber
identity module (SIM) card, with 16% owning two or
more SIM cards. Overall use of mobile phones to make
or receive an SMS was high. Younger respondents were
significantly more likely to make use of the SMS func-
tion, use WhatsApp (a cross-platform mobile messa-
ging application that uses the internet for sending text
messages, images and videos) and access the internet,
compared to older respondents.
Theft or loss of mobile phones
Although most health care providers were in favour of
using an SMS to convey Pap smear results and for col-
poscopy appointment reminders, many were concerned
that the SMS might not reach the intended client be-
cause of potential loss or theft of mobile phones.
“There could be challenges … you just send the
SMS, so the results might end up landing with the
wrong person and maybe the phone got lost or
stolen.” (Health manager, > 60 years old)
The perceived high rate of mobile phone loss or theft
was confirmed in the cross-sectional survey. Overall 58%
of survey respondents had ever experienced mobile
phone loss or theft (Table 2), with 28% of all respondent
Table 1 Profile of participants who currently owned a mobile phone
Characteristic < 30 years (n = 187) ≥ 30 years (n = 177) Total (N = 364) P-valuea
Median age in years (IQR) 25 (23–28) 37 (32–42 29 (25–36)
Main home language
Afrikaans 13 (7%) 21 (11.9%) 34 (9.3%) 0.272
English 1 (0.5%) 3 (1.7%) 4 (1.1%)
isiXhosa 165 (88.2%) 145 (81.9%) 310 (85.2%)
Other 8 (4.3%) 8 (4.5%) 16 (4.4%)
Languages spoken (after main home language)
Afrikaans 29 (15.5%) 45 (25.4%) 74 (20.3%) 0.019
English 158 (84.5%) 132 (74.6%) 315 (86.5%) 0.012
isiXhosa 174 (93.1%) 150 (84.8%) 324 (89.0%) 0.011
Other 25 (13.4%) 27 (15.3%) 52 (14.3%) 0.607
Highest level of education 0.007b
Primary or less 16 (8.6%) 35 (19.8%) 51 (14.0%)
Secondary 167 (89.3%) 137 (77.4%) 304 (83.5%)
Post-secondary 4 (2.1%) 5 (2.8%) 9 (2.5%)
Formal housing 83 (44.4%) 81 (45.8%) 164 (45.1%) 0.792
Median number of people living in home (IQR) 4 (3–6) 4 (3–5) 4 (3–6) 0.029c
Employed 52 (27.8%) 81 (45.8%) 133 (36.5%) < 0.001
(IQR Interquartile range)
aP-value for Chi-squared test unless otherwise stated
bFishers exact test
cKruskal-Wallis test
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having experienced mobile phone loss or theft in the
past year. During the FGDs with colposcopy clients
some suggested that to overcome problems of theft or
loss, the SMS should also be sent to a person that the
client trusts (e.g. close family or friend) and this person
could then forward the SMS to the intended recipient.
“Yes, the SMS is okay - however later your phone is
lost or stolen. I think it would be better if they can also
take contact details of a family member you trust so
that they can also send the SMS to him/her. In that
way that person will bring the notification to your
attention.” (FGD3)
Confidentiality
Some health care providers were concerned that com-
municating via SMS could breach confidentiality be-
cause of possible sharing of mobile phones in the
communities they served.
“Many of our patients are not working and cannot
afford a cell phone… Now, because not everybody
owns a cell phone, they share it, sometime leave
with a neighbor to charge the battery and the fear
is confidentiality as other people might see the
SMS.” (Clinical nurse practitioner, 40–50 years old)
Half of the cross-sectional survey respondents and the
majority of the FGD participants (85%) indicated that
someone else had access to their phone, usually a family
member. Some FGD participants raised concerns about
an SMS from the clinic being seen by someone else.
“I don’t like messages sent to my phone, sometimes
you leave your phone on a charger and a message
comes in, someone picks it up and reads without
your permission.” (FGD4)
Receiving pap smear results via SMS
Most (72%) survey respondents were interested in re-
ceiving Pap smear results by SMS. Reasons for interest
included convenience, cost and time saving and the
benefit of not needing to take time off work. These
views were echoed by colposcopy clients.
“Getting a SMS is very good because now you know for
sure that your Pap smear results are available, instead
of being given a return date only to find out when
Table 2 Mobile phone ownership and patterns of use
Characteristic < age 30 (n = 187) ≥ age 30 (n = 177) Total sample (N = 364) P-valuea
Mobile phone type
Basic 60 (32.1%) 68 (38.4%) 128 (35.2%) 0.001
Smart/Feature 127 (67.9%) 98 (55.4%) 225 (61.81%)
Unknown 0 (0%) 11 (6.21%) 11 (3.0%)
Cash purchase of phone (as opposed to contract) 177 (94.7%) 169 (95.5%) 346 (95.1%) 0.716
Median time owned mobile phone (IQR) 12 months (5–24) 8 months (6–36) 12 months (5–30) < 0.001
Ever lost or had mobile phone stolen 115 (61.5%) 95 (53.7%) 210 (57.7%) 0.031
Someone else has access to phone 99 (52.9%) 84 (47.5%) 183 (50.3%) 0.296
Owns SIM card 183 (97.9%) 174 (98.3%) 357 (98.1%) 0.758
Ever uses someone else’s SIM card 12 (6.4%) 8 (4.5%) 20 (5.5%) 0.427
Ways phone is used
Receive SMS 187 (100%) 170 (96.1%) 357 (98.1%) 0.006b
Send SMS 186 (99.5%) 165 (93.2%) 351 (96.4%) 0.001b
Make calls 187 (100%) 177 (100%) 364 (100%) –
Receive calls 187 (100%) 175 (98.9%) 362 (99.5%) 0.236b
Send money 13 (7%) 14 (7.9%) 27 (7.4%) 0.727
Receive money 15 (8%) 16 (9%) 31 (8.5%) 0.728
WhatsApp 103 (55.1%) 67 (37.9%) 170 (46.7%) 0.001
Mxit 35 (18.7%) 21 (11.9%) 56 (15.4%) 0.070
Browse internet 84 (44.9%) 51 (28.8%) 135 (37.1%) 0.001
Send/receive emails 36 (19.3%) 21 (11.9%) 57 (15.7%) 0.053
aP-value for Chi-squared test unless otherwise stated
bFishers exact test
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you get there your results have not yet been received.
Remember, we are working and we take time off work to
come to the clinic.” (FGD2)
“Sometimes SMS is better than calls because sometimes
when a hospital calls you whilst you are busy and can’t
pick up the phone and they will not call you again to
give you the results.” (FGD4)
Health care providers also suggested that the SMS sys-
tem would be more convenient for women and an effi-
cient use of resources.
“I think that for me it could be a very good thing
[using SMS] that is also convenient for the patient
because nowadays patients are becoming well informed
health-wise because they themselves will come and
ask you, maybe they did a Pap smear last week,
saying “sister are my Pap smear results not yet
available”. They are also concerned about their
health status which is a beautiful thing.” (Clinical
nurse practitioner, 40–50 years old)
“I would recommend or support that the SMS system
… I mean if we can manage time well and also optimal
utilization of resources, the SMS will instantly reach
the patient and she will receive the results.” (Health
manager, 50–60 years old)
Results of the logistic regression analysis on factors
associated with interest in receiving Pap smear results
via SMS are summarized in Table 3. Women with
higher education level and a previous Pap smear were
significantly more interested in receiving results via an
SMS (adjusted odds ratio (aOR) 2.15 (aOR) and 1.78
(aOR), respectively). Respondents were significantly less
likely to want to receive Pap smear results via SMS if
someone else had access to their mobile phone (aOR
0.31, 95% CI 0.18–0.51). Although HIV positive women
were less interested in receiving Pap smear results via
an SMS compared to HIV negative women, this differ-
ence was not statistically significant.
Most FGD participants mentioned it would be accept-
able to convey normal results via SMS, but not abnormal
results. In the event of abnormal results, participants
generally felt the message should simply read: “please
come to the clinic.”
“If the results are okay they can let me know that I
don’t need to worry my results are normal however if
there is something wrong I would prefer that they do
not put it in the SMS rather send SMS asking me to
come to the clinic so that they can explain everything
to me.” (FGD2)
Many health care providers were also concerned about
clients being given abnormal results outside the clinic
environment, preferring face-to-face discussions.
“So when I give the results via SMS there is no one to
explain to them what the results mean” (Professional
nurse, < 30 years old)
“For some, if you say maybe there is a lesion,
immediately they think of cancer and get so worked
up but if you interpret and tell the patient what is
actually happening to relieve that anxiety you are
bound to get a positive result and they will likely
honor the appointment scheduled for them…Now
I’m not sure if you can put all that in an SMS to
alleviate the patient from any anxiety she might
have.” (Clinical nurse practitioner, 40 – 50 years old)
Receiving appointment reminders via SMS
The majority of survey respondents (77%) were inter-
ested in receiving clinic or hospital appointment re-
minders. However, HIV positive women were 0.3 times
less interested in receiving appointment reminders via
SMS compared to HIV negative women (aOR 0.33, 95%,
CI 0.15–0.75), whilst women who spoke Afrikaans were
significantly more interested in receiving appointment
reminders (aOR 3.01, 95% CI 1.23–7.37) (Table 4).
Table 3 Factors associated with interest in receiving Pap smear
results via SMS
Variable Adjusted OR (95% CI)a P-value
Uses text 4.34 (0.54–34.94) 0.168
Completed high school 2.15 (1.16–3.98) 0.015
Previous pap smear 1.78 (1.04–3.07) 0.037
Phone not private 0.31 (0.18–0.51) < 0.001
HIV positive 0.65 (0.34–1.25) 0.196
aAdjusted by all the variables reported in the table
Table 4 Factors associated with receiving appointment reminders
via SMS
Variable Adjusted OR (95% CI)a P-value
Uses text 14.19 (1.72–117.13) 0.014
HIV positive 0.33 (0.15–0.75) 0.008
Afrikaans speaking 3.01 (1.23–7.37) 0.016
Phone not private 0.83 (0.49–1.41) 0.495
Complete high school 1.26 (0.70–2.27) 0.435
Previous Pap smear 0.80 (0.44–1.45) 0.455
aAdjusted by all variables reported in the table
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FG participants reported waiting for up to 7 months
for a colposcopy appointment. The majority indicated
interest in receiving appointment reminders, with most
preferring to receive two reminders, one soon after the
colposcopy appointment is made and a second between
1 to 7 days before the appointment date.
Health care providers were in favour of sending clients
appointment reminders via SMS for similar reasons ar-
ticulated by FGD respondents.
“Usually the appointment is in four weeks, so nearer to
the time you can send an appointment reminder.
Others do forget genuinely, you see them when they
come to the clinic [primary health care clinic] whereas
they were supposed to attend the colposcopy clinic. I
really think it would work to the patient’s advantage.”
(Clinical nurse practitioner, 40 – 50 years old)
Language
Some cross-sectional survey respondents did not want to
receive Pap smear results via SMS because of potential
difficulty in understanding the message. Both FG discus-
sants and health care providers emphasized the import-
ance of using simple written language and highlighted
potential difficulties with use of medical terminology.
“They can say anything as long as they use simple easy
to follow language.” (FGD3)
“I prefer it to be in English because there are some
words that cannot be communicated in isiXhosa.
Sometimes it becomes difficult to read medical
terms on isiXhosa.” (FGD3)
“...in a language that would be understood by the client.”
(Clinic manager, 30 – 40 years old)
Management of a clinic-based SMS system
All health care providers were familiar with using mobile
phones and some had used their personal phones to
contact clients via text.
“We [practitioners] do not have access to call cell phones
[from the clinic landline] … I call them using my
[personal] cell phone and sometimes send a message
[SMS]...” (Professional nurse, 30–40 years old)
However, healthcare providers had no experience of a
clinic-based SMS system. Some were unaware that SMS
messages could be computer generated and suggested
that clinics should have dedicated mobile phones for
SMS communication with clients.
In discussion on how a clinic-based SMS system could
work, health care providers recommended the following:
confirming phone numbers at each clinic visit, clients be
given an option of whether they wanted to receive SMS
notification of results, and that clients are informed as
to when they can expect the SMS notification. Some felt
that only clients with abnormal results be sent an SMS,
and by implication clients that did not receive an SMS
would interpret this as having a normal Pap smear re-
sult. Others were concerned about non-receipt of the
SMS and preferred that clients be asked to confirm re-
ceipt. Some suggested that clients be instructed that if
an SMS is not received within a defined period, then
they should return to the clinic.
“The nurse will also confirm the phone numbers…of
the patient and ask the patient if it would be okay to
phone them. So, they have got an arrangement with
the clients, that says so if you do not get an SMS from
me you must know your result is okay but if you do
receive an SMS from me then you must know that you
must come to the clinic for your results.” (Operational
manager, > 60 years old)
There were mixed views on who should be responsible
for managing a clinic-based SMS system. Some felt that
the health care provider performing the Pap smear
should be responsible for sending the SMS as a relation-
ship had already been established between the provider
and client and that administrative staff would not under-
stand the urgency of contacting clients and ensuring that
clients responded.
“The cervical smear portfolio holder [should be
responsible for sending the SMS], because she is
the one in contact with the clients because she is
the one performing, taking smears from the patients
and teaching and educating them about the smears.
So that relationship needs to continue and the
patient has already established a relationship with
that person.” (Clinic manager, 30–40 years)
Others felt that it would be an additional burden on
the health care providers’ already heavy workload, and
that the task should be the responsibility of the admin-
istrative staff. A few suggested it should be the respon-
sibility of the health educators.
Discussion
The use of mhealth in the management of communicable
and non-communicable diseases is increasing [32–38]
with some evidence that SMS interventions could improve
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treatment adherence, increase appointment attendance
and support behavior change [39–45]. However, limited
research is available on the feasibility of mhealth in the
control and management of cervical cancer in low- and
middle-income countries (LMICs) [32]. Consequently,
there is an important need for formative research to guide
the development and implementation of mhealth inter-
ventions in these settings.
This study showed that the vast majority of women
eligible for a Pap smear at public sector primary health
care clinics in SA owned a mobile phone. Additionally,
women were familiar with sending and receiving SMS
text messages, making mobile phone technology a po-
tential mechanism to improve follow-up and manage-
ment in a cervical cancer screening program. Both
women and health care providers were interested in
using mobile phones to convey Pap smear results, with
most preferring the SMS text to indicate availability ra-
ther than the actual result, particularly for abnormal
smears.
In countries where access to a fixed-line telephone is
limited, the mobile phone is rapidly becoming an im-
portant means of sending appointment reminders [46].
Missed colposcopy appointments are a major barrier to
cervical cancer prevention and treatment in SA. In our
study there was considerable support for an SMS colpos-
copy clinic appointment reminder system. Given the
long waiting time for a colposcopy appointment in the
public-sector health system, it is not surprising that par-
ticipants suggested a minimum of 2 reminders, with the
2nd being closer to the appointment date.
Our research also highlighted several issues that need
to be addressed in designing an mhealth intervention to
improve Pap smear management. Similar to Crankshaw
et al. [36] participants in our study reported a high loss
of mobile phones (58% had ever lost a mobile phone,
28% in the preceding year). This has implications for the
success and sustainability of any mhealth intervention.
Although participants suggested regular updating of mo-
bile phone numbers at clinic visits as a possible solution
to the high mobile phone turnover, this has limited
value for cervical cancer screening clients who typically
are asymptomatic and therefore unlikely to visit the
clinic regularly. Another solution is for mHealth inter-
ventions to make provision for clients to send a free
confirmation of receipt of an SMS. This will assist
clinic managers in identifying those that did not receive
the text message and therefore require follow-up via
other clinic client-tracking systems such as via commu-
nity health workers.
Previous studies have highlighted the importance of
privacy with SMS based interventions [36, 46, 47]. In
our study many clients reported that others had access
to their mobile phones, with concerns about confidentiality
raised by both providers and clients. Clients who re-
ported that others were likely to have access to their
messages were significantly less interested in receiving
Pap smear results via SMS. HIV positive clients were
also significantly less interested in receiving appoint-
ment reminders, possible due to privacy concerns. In
designing an intervention, providers would need to dis-
cuss the possibility of breaks in confidentiality and con-
firm clients’ interest in receiving text messages before
enrollment. Interventions that require a password to
access messages could provide privacy, however client
trust in such interventions will need to be explored.
Difficulty in understanding text messages could be a
potential barrier to uptake of an SMS intervention
[34]. Our results concur with others on the import-
ance of careful development of text messages [48, 49],
with attention to use of simple, clear language and ac-
curate translation into local languages. Careful piloting
of specific mobile text messages with assessment of
understanding and acceptance of messages will also be
required.
Any mhealth intervention will need to carefully con-
sider integration into existing and developing public
sector health information and management systems
[20, 34, 50, 51]. Mhealth interventions will be greatly
facilitated by electronic patient clinic records and elec-
tronic appointment booking systems [50]. Currently
this is largely unavailable in the SA public health sys-
tem. Health care providers have limited experience of a
clinic-based SMS system and will require information
and training. Issues related to roles and responsibilities
in terms of management of a SMS intervention were
raised and coherent policy and guidelines will need to
be developed. In addition, development of relevant data
security policy that protects client information during
message transmission and data storage will be also crit-
ical as the mHealth field of develops. The current lack
of supporting policy has been identified as an important
barrier to implementation of mhealth interventions
worldwide [46, 50].
As our study was conducted in an urban setting
where mobile phone ownership is higher compared to
rural areas (85% vs. 68%), findings are unlikely to be
generalizable to rural areas [52]. A limitation of our
study was that all client interviews were conducted at
health facilities. Although clients were informed that
their participation and responses would not affect the
care received, it is possible that some degree of courtesy
bias could have resulted in an overestimate of client
willingness to receive Pap smear results and appoint-
ment reminders via SMS. Detailed reflective notes
were kept during focus group discussions and contrib-
uted to interpretation of findings, however interactions
between participants were not analyzed.
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Conclusion
Results from this study demonstrate that mHealth inter-
ventions, specifically the use of SMS text-based messaging,
are perceived positively by the majority of the women
interviewed. Such interventions may tackle health system
inefficiencies in the communication of test results and ap-
pointment attendance. However, important issues, includ-
ing confidentiality and privacy concerns as well as the
integration and management of mHealth interventions
into the broader health information system, will need to
be addressed for this potential to be realized.
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